Symptom Support:
• Mood Support
• Fatigue Relief
• Blood Sugar Balance
• Joint & Muscle Support
• Digestive Support
Functional Benefits:
• Protein, fiber, and healthy fats for satiety
• Rich in antioxidants and vitamin E
• Naturally sweet without added sugars
• Portable, easy, and satisfying
Symptom Support:
• Hormone Balance
• Heart & Circulation
• Weight Management
• Skin & Hair Health
• Joint & Muscle Support
Functional Benefits:
• Rich in potassium and magnesium
• Provides plant-based omega fats
• Balances blood sugar and keeps you full
• Quick, satisfying, and nutrient-dense
Symptom Support:
• Cognitive Function
• Fatigue Relief
• Heart & Circulation
• Blood Sugar Balance
• Joint & Muscle Support
Functional Benefits:
• Complete protein from eggs
• Walnuts contain ALA (a plant-based omega-3)
• Nutrient-dense and highly satiating
• No sugar, no prep if pre-cooked
Symptom Support:
• Cognitive Function
• Hormone Balance
• Mood Support
• Fatigue Relief
• Heart & Circulation
Functional Benefits:
• Nutrient-dense and travel-friendly
• Combines protein, fiber, and antioxidants
• Naturally sweet with no added sugars
• Satisfying and crunchy
Symptom Support:
• Hot Flashes & Night Sweats
• Digestive Support
• Joint & Muscle Support
• Mood Support
• Fatigue Relief
Functional Benefits:
• Rich in potassium, magnesium, and fiber
• Plant-based and phytonutrient-rich
• Cooling and hydrating
• Supports blood sugar stability and satiety
• Naturally anti-inflammatory
Gedeon Richter has launched Nalvee, a dydrogesterone-only HRT option, in the UK after a 17-year absence. The treatment offers women a new progestogen choice with predictable bleeding patterns and strong endometrial protection for menopause symptom management.
A year-long study of Elinzanetant (Lynkuet) reveals lasting relief from hot flashes and improved sleep without hormones. Here’s what you need to know about this breakthrough non-hormonal option.
In the UK, a testosterone cream formulated specifically for women was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in August 2025. Before this, testosterone was not licensed for women, and male-strength gels were prescribed "off-label" in lower doses, as is currently the case in the US and elsewhere.
An FDA-convened panel of medical experts heard testimony in July 2025 supporting the removal of the black box warning from low-dose vaginal estrogen therapies. Experts argued that the warning, which dates to 2003, is inaccurate and scares women away from a safe and effective treatment for menopausal symptoms.
This new perspective contrasts with the widespread alarm caused by the initial 2002 Women's Health Initiative (WHI) trial findings, which suggested serious risks and led many women and doctors to avoid hormone therapy (HT). Current research clarifies that those risks were primarily associated with older participants who began therapy many years after menopause using older, higher-dose formulations.
The U.S. Food and Drug Administration approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause. Veozah is the first neurokinin 3 (NK3) receptor antagonist approved by the FDA to treat moderate to severe hot flashes from menopause. It works by binding to and blocking the activities of the NK3 receptor, which plays a role in the brain’s regulation of body temperature.
Could menopause one day be optional? Scientists are exploring radical new ways to delay or even prevent it, from ovarian tissue freezing to groundbreaking hormonal research.
Early clinical research indicates that a weekly rapamycin pill could delay menopause by slowing the aging of the ovaries. A pilot study conducted at Columbia University showed promising results, and a larger trial is now underway. While the findings are encouraging, this treatment is still experimental, and its long-term safety and efficacy need further confirmation.
A major study reveals women’s heart health declines rapidly after menopause, making this a crucial time for screening, prevention, and awareness.
Elinzanetant (Lynkuet) is a new non-hormonal therapy under FDA review that could finally provide relief from hot flashes for women who can’t or prefer not to take hormone therapy. Promising trial results offer hope for midlife symptom relief.
Menopause doesn’t have to mean relying solely on hormones for symptom relief. NK3 antagonists, including Veozah and Elinzanetant, are e...
Discover Veozah, the first FDA-approved non-hormonal medication for menopause hot flashes. Learn how it works, who's a good candidate,...
Hearing loss during menopause is often linked to declining estrogen levels that affect the auditory system, making it harder to hear hi...
Your words can spark connection, relief, and “me too” moments for women who need it most. The messy, funny, frustrating truth—it all matters.
Tell us what you’ve learned, what you’re still figuring out, or what no one warned you about.
Every woman has her secret weapons—maybe a tea, a supplement, or that one product that saved your sanity.
Share what’s working for you—the real-world stuff you’d tell your best friend. Together, we’ll build a library of what actually helps.
Sign up for down-to-earth menopause insights, symptom-soothing strategies, and tools that actually make sense. Delivered with empathy (and maybe a little humor).
No fluff—just helpful, reliable info.